Braden Parker

Mr. Parker has served as Savara’s Chief Commercial Officer since September 2024. With more than 25 years of experience in the healthcare and biotech industry, Mr. Parker is a seasoned commercial leader who has developed and executed global commercial plans, built high-performance teams, and launched multiple successful rare disease products. Previously, Mr. Parker was the Chief Commercial Officer at Orchard Therapeutics (Kyowa Kirin) where he was responsible for global commercial strategy, including overseeing Orchard Therapeutics’ first product launch. Prior to that, Mr. Parker served as Vice President and General Manager for the U.S. organization for PTC Therapeutics and led the company’s first U.S. product launch. Earlier in his career, Mr. Parker held commercial leadership roles at Celgene and NPS Pharma (Shire). Mr. Parker holds an M.B.A. from New York University Stern School of Business and a B.B.A. from the University of Notre Dame.